v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS – OPERATING ACTIVITIES    
Net loss $ (3,214) $ (20,678)
Adjustments required to reconcile cash flows used in operating activities:    
Depreciation and amortization 882 659
Stock-based compensation 1,083 641
Amortization of debt issuance costs 453
Finance income, net (478) (293)
Revaluation of contingent consideration 6 (40)
Income from change in fair value of Private Placement Warrants (24,417)
Private Placement Warrants issuance cost 732
Change in contract liability (1,976)
Loss from sale and disposal of fixed assets, net 145
Goodwill impairment 801
Changes in operating assets and liabilities:    
Other current and non-current assets (213) 679
Trade accounts payable (2,691) 241
Other accounts payable (1,169) 3,354
Net change in operating leases (181) (60)
Net cash used in operating activities (30,690) (15,044)
CASH FLOWS – INVESTING ACTIVITIES    
Cash and restricted cash acquired from the APT acquisition 663
Proceeds from short-term deposits 2,000
Proceeds from sale of property and equipment 72
Purchases of property and equipment (19) (43)
Net cash provided by investing activities 716 1,957
CASH FLOWS – FINANCING ACTIVITIES    
Issuance of Private Placement Warrants under March 2024 PIPE 28,745
Issuance of Redeemable Convertible Preferred Shares under March 2024 PIPE 21,269
March 2024 PIPE issuance costs (507)
Issuance costs from February 2023 PIPE (333)
Issuance of Common Stock and Warrants under February 2023 PIPE 7,485
Pre-Funded Warrants exercise 6
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs 19
Issuance cost from the APT acquisition (13)
Repayment of long-term debt (10,747) (2,929)
Net cash provided by financing activities 38,772 4,223
Increase (decrease) in cash and cash equivalents and restricted cash 8,798 (8,864)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (11) (37)
Cash and cash equivalents and restricted cash at the beginning of the period 15,864 32,294
Cash and cash equivalents and restricted cash at the end of the period 24,651 23,393
RECONCILIATION OF AMOUNTS ON CONSOLIDATED BALANCE SHEETS    
Cash and cash equivalents 23,537 22,450
Restricted cash 1,114 943
Total cash and cash equivalents and restricted cash 24,651 23,393
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid for interest 1,437 1,455
Taxes paid 10 50
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Property and equipment purchases included in accounts payable and Trade payable 11 5
Issuance cost from March 2024 PIPE 1,685
Issuance of Common Stock under the APT acquisition 3,041
Issuance of Redeemable Convertible Preferred Shares under the APT acquisition 12,610
Issuance of Merger Warrants under the APT acquisition 200
Redeemable Convertible Preferred Shares conversion into shares of Common Stock $ 13,774

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL